Repository logo
Communities & Collections
Research Outputs
Fundings & Projects
People
Statistics
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. KMITL
  3. Publication
  4. Cytotoxic pentacyclic and tetracyclic aromatic sesquiterpenes from phomopsis archeri
Loading...
Thumbnail Image

Cytotoxic pentacyclic and tetracyclic aromatic sesquiterpenes from phomopsis archeri

Author(s)
Hemtasin, Chulida
Kanokmedhakul, Somdej
Kanokmedhakul, Kwanjai
Hahnvajanawong, Chariya
Soytong, Kasem
Prabpai, Samran
Kongsaeree, Palangpon
Date Issued
April 25, 2011
Type
Article
DOI
10.1021/np100632g
Abstract
Three new sesquiterpenes, named phomoarcherins A-C (1-3), and four known compounds, kampanol A (4), R-mevalonolactone, ergosterol, and ergosterol peroxide, were isolated from the endophytic fungus Phomopsis archeri. These structures were established on the basis of spectroscopic evidence. The structure and absolute configuration of 1 were confirmed by X-ray crystallographic analysis of its p-bromobenzoate derivative (1a). Compounds 1-4 showed cytotoxicity against five cholangiocarcinoma cell lines (0.1-19.6 μg/mL), while 1 and 2 exhibited weak cytotoxicity against the KB cell line with IC50 values of 42.1 and 9.4 μg/mL, respectively. In addition, compound 2 showed antimalarial activity against Plasmodium falciparum with an IC50 value of 0.79 μg/mL. © 2011 The American Chemical Society and American Society of Pharmacognosy.
Citation
Journal of Natural Products, 74(4), 609-613, 2011
Metrics
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback